• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 22, 2023 at 07:02: PM
via Gilead Sciences is no stranger to legal claims surrounding its market-leading HIV franchise. Now, the company and two other major biopharma players are heading to trial over claims they worked together to restrict competition in the marketplace.

article source
 




Top Bottom
Back
Quote